Medical imaging is integral to the evolution of breast cancer clinical trials providing crucial insights into tumor detection and treatment evaluation. Mammography and ultrasound are the standard imaging modalities for screening and initial diagnosis, MRI helps determine the extent of… Read More
Prostate cancer is the most common cancer among men and the second leading cause of cancer death after lung cancer. Advances in imaging techniques, particularly multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT (that Imaging Endpoints helped… Read More
Lymphoma treatment is undergoing a remarkable transformation through the integration of advanced imaging biomarkers. Updated CT and PET response criteria are improving assessment strategies, while other functional imaging methods offer new insights into treatment efficacy. Amidst these technological advancements, bone… Read More
Imaging plays a crucial role in the diagnosis and management of lung cancer, which remains a leading cause of cancer-related deaths worldwide. Radiological methods like CT (including low-dose) and PET, have become essential for early detection, staging, and ongoing monitoring… Read More
Glioblastoma multiforme (GBM) is the most malignant and prevalent subtype of glioma, representing the most common primary brain tumor in adults. MRI is considered the gold standard for assessing glioblastoma. However, structural MRI alone is insufficient for accurately interpreting treatment-related… Read More
Gastrointestinal Stromal Tumors (GIST) pose unique challenges in clinical settings due to their distinct molecular features and behaviors. Imaging plays a pivotal role in evaluating diagnosis and treatment agents in GIST clinical trials. Various imaging techniques are utilized for monitoring… Read More
Sarcomas and bone tumors pose a distinctive challenge in oncology imaging, necessitating standardized protocols for precise tumor response determination in clinical trials. Multiple imaging techniques are needed to address the heterogeneity of these tumors. Imaging Endpoints applies the leading and… Read More
Hematologic cancers, originating from lymphoid and myeloid cell lines, represent about 10% of newly diagnosed malignant tumors in the United States. Among these, Multiple Myeloma survival has improved over the last decade, with the emergence of cutting-edge therapies like CAR… Read More
To arrange a conversation with our proficient medical and scientific affairs experts and discover how we can help your clinical trials with tailored imaging solutions
The evolution of cancer treatment is experiencing the emergence of immune checkpoint blockade as a promising strategy with distinct response patterns and challenges. Medical imaging plays a pivotal role in evaluating responses to immunotherapy and monitoring immune-related adverse events, challenging… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
